Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Rituximab
•
IVIG
•
General Rheumatology
How do you time concurrent therapy with rituximab and IVIG?
Related Questions
Are serologies reliable in a patient undergoing workup for autoimmune disease who is receiving IVIG for a different indication?
Do you hold rituximab for cataract surgery?
How do you approach management of a patient with persistent EBV infection and MAS despite treatment with Rituximab, anakinra and canakinumab?
Do you consider IgM or IgA levels in addition to IgG levels when planning further doses of rituximab?
What baseline and ongoing testing do you recommend for patients with PMR who are going to be on a prolonged steroid taper?
How do you approach pre-conception counseling in males who are on medications for which there is limited or no data such as Jak inhibitors, apremilast, or belimumab?
Do you restrict topical diclofenac use in your patients with chronic kidney disease?
What would be in your differential diagnosis for a patient with bone infarcts near the knee (distal femoral diaphysis and proximal tibial diaphysis) as well as bilateral hips?
Would you use a reduced dose glucocorticoid tapering regimen for patients with vasculitis due to Sjögren’s syndrome treated with Rituximab?
What is your approach to RSV vaccination in immunocompromised patients?
